Financials
- Market Capitalization 454.17 M
- Employee 371
- Founded 2008
- CEO N/A
- Website www.regenxbio.com
- Headquarter Maryland, United States
- FIGI BBG007Z9V591
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-3.83
Fiyat/satışlar oranı
4.36
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2870 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 7.55 USD | -5.39% | -14.20% | -28.16% | -3.33% | 469.30 M USD | ||
| 2887 | YDES YD Bio Limited - Ordinary Shares | 6.36 USD | +4.26% | +9.47% | +63.08% | -66.51% | 450.22 M USD | ||
| 2896 | AUTL Autolus Therapeutics plc - American Depositary Shares | 1.69 USD | +4.32% | -5.06% | -12.44% | -4.52% | 449.81 M USD | ||
| 2897 | ALT Altimmune, Inc. - Common Stock | 2.31 USD | -4.94% | -12.83% | -28.92% | -42.25% | 449.34 M USD |